BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11684412)

  • 1. Merlin: hanging tumor suppression on the Rac.
    Sherman LS; Gutmann DH
    Trends Cell Biol; 2001 Nov; 11(11):442-4. PubMed ID: 11684412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
    Wong HK; Shimizu A; Kirkpatrick ND; Garkavtsev I; Chan AW; di Tomaso E; Klagsbrun M; Jain RK
    Neoplasia; 2012 Feb; 14(2):84-94. PubMed ID: 22431917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.
    Shaw RJ; Paez JG; Curto M; Yaktine A; Pruitt WM; Saotome I; O'Bryan JP; Gupta V; Ratner N; Der CJ; Jacks T; McClatchey AI
    Dev Cell; 2001 Jul; 1(1):63-72. PubMed ID: 11703924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21-activated kinase links Rac/Cdc42 signaling to merlin.
    Xiao GH; Beeser A; Chernoff J; Testa JR
    J Biol Chem; 2002 Jan; 277(2):883-6. PubMed ID: 11719502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional analysis of neurofibromatosis 2 (NF2) missense mutations.
    Gutmann DH; Hirbe AC; Haipek CA
    Hum Mol Genet; 2001 Jul; 10(14):1519-29. PubMed ID: 11448944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.
    Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D
    J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate.
    Sun CX; Haipek C; Scoles DR; Pulst SM; Giovannini M; Komada M; Gutmann DH
    Hum Mol Genet; 2002 Dec; 11(25):3167-78. PubMed ID: 12444101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling.
    Kim S; Jho EH
    BMB Rep; 2016 Jul; 49(7):357-8. PubMed ID: 27345717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.
    Petrilli A; Bott M; Fernández-Valle C
    Oncotarget; 2013 Dec; 4(12):2354-65. PubMed ID: 24259290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.
    Kissil JL; Wilker EW; Johnson KC; Eckman MS; Yaffe MB; Jacks T
    Mol Cell; 2003 Oct; 12(4):841-9. PubMed ID: 14580336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression.
    Rong R; Surace EI; Haipek CA; Gutmann DH; Ye K
    Oncogene; 2004 Nov; 23(52):8447-54. PubMed ID: 15378014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurofibromatoses: when less is more.
    Gutmann DH
    Hum Mol Genet; 2001 Apr; 10(7):747-55. PubMed ID: 11257108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation.
    Huang J; Chen J
    Oncogene; 2008 Jul; 27(29):4056-64. PubMed ID: 18332868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on Tumor Biology in Vestibular Schwannoma.
    Nourbakhsh A; Dinh CT
    Otolaryngol Clin North Am; 2023 Jun; 56(3):421-434. PubMed ID: 37121611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function.
    Yang C; Asthagiri AR; Iyer RR; Lu J; Xu DS; Ksendzovsky A; Brady RO; Zhuang Z; Lonser RR
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4980-5. PubMed ID: 21383154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of
    Gerardo-Ramírez M; Giam V; Becker D; Groth M; Hartmann N; Morrison H; May-Simera HL; Radsak MP; Marquardt JU; Galle PR; Herrlich P; Straub BK; Hartmann M
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuronal function of the tumor suppressor protein merlin.
    Schulz A; Zoch A; Morrison H
    Acta Neuropathol Commun; 2014 Jul; 2():82. PubMed ID: 25012216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.